Significant group differences in white matter integrity. by Anya Topiwala (4330432)

“…<p>Voxels where there were significant differences in white matter integrity between resilient (N = 184) and non-resilient (N = 133) groups are shown in colour. …”

Results showing significant GM differences between the HC and mAD groups. by Yubraj Gupta (7465394)

Groupings based on deformity and jig type used. by Stephanie K. Steuri (19681369)

Subjects:

Spikes of (significant) time bins. by András Ecker (18137289)

Health assessment questions. by Tamara M. Masters (14094156)

Subjects:

Forest plot of mouse movement time z scores by treatment and gender. by Tamara M. Masters (14094156)

Subjects:

Mouse tracking time and distance to final response (z score). by Tamara M. Masters (14094156)

Subjects:

Statements for treatments. by Tamara M. Masters (14094156)

Subjects:

Forest plot of mouse movement distance z score by treatment and gender. by Tamara M. Masters (14094156)

Subjects:

Forest plot of answer adjustment by treatment and gender. by Tamara M. Masters (14094156)

Subjects:

Answer adjustment measures (abs) by treatment for combined questions: Weight, EtOH, drugs, OD, smoke, exercise, sex. by Tamara M. Masters (14094156)

Subjects:

Count of individuals randomly assigned to each condition. by Tamara M. Masters (14094156)

Subjects:

Bacterial groups that showed a significantly decreased abundance after antibiotic treatment (AMC and DOX group) compared to the control group (CON group). by Evangelia M. Stavroulaki (11840809)

Matrix of significance for the MMD values based on the relationship MMD>2SD. by Erica Piccirilli (17200066)

BA attenuated the decrease in the integrity and increase in the permeability of the epithelial barrier injury induced by LPS in Caco2 cell monolayers. by Luqiong Liu (11537092)

Radar graph of odds ratio visualization for disease milestones difference by age and disease duration. by Sasivimol Virameteekul (11868977)

Subjects:

Radar graph of absolute correlations between age, disease duration and disease variables. by Sasivimol Virameteekul (11868977)

Subjects:

Comparison of demographic and clinical characteristics for old-old PD patients with disease duration <10 years versus those with disease duration ≥10 years. by Sasivimol Virameteekul (11868977)

Subjects:

Distribution of the global population in 2020 [4] and prevalence of global Parkinson’s disease in 2016, by age [5]. by Sasivimol Virameteekul (11868977)

Subjects:

Comparison of demographic and clinical characteristics of old-old versus young-old PD patients. by Sasivimol Virameteekul (11868977)

Subjects: